Company / Tangible Book Value per Share
Enliven Therapeutics, Inc. Tangible Book Value per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$6.58
FY2024
5-year range
-$24.59 / $6.92
FY2020-FY2024
Trend
-4.9%
vs FY2023
Sector context
#80 of 209
Health Care
What the data says
At $6.58, Enliven Therapeutics, Inc.'s tangible book value per share ranks #80 of 209 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 6 years, ranging from $-69.54 in FY2019 to $6.92 in FY2023.
Based on SEC 10-K filings.
6.58 in FY2024.
Improved from $-24.59 to $6.58 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#80 of 209 in Health CareTop 38% of 209This company $6.58 Sector average $119.74
▼
-94.5% below sector average
Key checks
Key Insights
- In FY2024, tangible book value per share decreased 4.9% year-over-year.
- Ranks #80 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2023.
- Lowest tangible book value per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.84 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.58 | -4.9% |
| FY2023 | $6.92 | +128.1% |
| FY2022 | -$24.59 | -1142.0% |
| FY2021 | -$1.98 | -132.7% |
| FY2020 | $6.06 | +108.7% |
| FY2019 | -$69.54 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026